Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Daiken Medical Co., Ltd. (7775.T)
Izumi, JP
Daiken Medical Co., Ltd. is a global developer and provider of healthcare devices and equipment, serving both the Japanese market and international clientele. Its extensive product catalog includes syringe pumps, disposable and portable infusion pumps, endobronchial blocker tubes, a range of suction accessories (containers, connecting tubes, and tips), medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. Additionally, the company engages in the trade of other medical apparatus. All its offerings are marketed under the COOPDECH brand. Established in 1968, Daiken Medical Co., Ltd. maintains its headquarters in Izumi, Japan.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.97% | -5.82% | -6.86% | -12.29% | -4.75% | -5.82% | -4.97% | -14.78% | -24.14% | -53.33% | +169.22% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Instruments & Supplies: +7.9%+3.4% Q1'26: +5.4% (vs Q1'25)
-
EPS growth Medical - Instruments & Supplies: +16.3%-15.9% Q1'26: -41.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%+3.4% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%+12.4% Q1'26: +6.7% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%+13.1% ★ Q1'26: +5.4% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×1.47× ★ Q1'26: 2.44× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 1 Rev. Ana. 1 EPS Ana. |
Mar 2027 1 Rev. Ana. 1 EPS Ana. |
Mar 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.03B
est: 8.07B (-0.5%)
|
8.26B
est: 8.26B (+0.1%)
|
8.40B
est: 8.45B (-0.6%)
|
8.59B
est: 8.65B (-0.7%)
|
8.41B
est: 8.40B (+0.1%)
|
8.52B
est: 8.46B (+0.8%)
|
7.86B
est: 8.00B (-1.7%)
|
8.54B
est: 8.43B (+1.4%)
|
9.14B
est: 9.13B (+0.1%)
|
9.75B
est: 9.80B (-0.5%)
|
9.95B
est: 10.10B (-1.5%)
|
10.20B
10.20B – 10.20B
+1.0% YoY
|
10.60B
10.60B – 10.60B
+3.9% YoY
|
11.30B
11.30B – 11.30B
+6.6% YoY
|
| EBITDA |
1.77B
est: 1.31B (+35.0%)
|
1.90B
est: 1.34B (+42.3%)
|
1.89B
est: 1.37B (+37.9%)
|
1.62B
est: 1.40B (+15.4%)
|
1.46B
est: 1.36B (+7.5%)
|
1.45B
est: 1.37B (+5.8%)
|
1.18B
est: 1.30B (-8.9%)
|
1.47B
est: 1.37B (+7.7%)
|
1.30B
est: 1.48B (-12.3%)
|
1.66B
est: 1.96B (-15.3%)
|
1.75B
est: 1.63B (+7.1%)
|
1.65B
1.65B – 1.65B
+1.0% YoY
|
1.72B
1.72B – 1.72B
+3.9% YoY
|
1.83B
1.83B – 1.83B
+6.6% YoY
|
| EBIT |
1.61B
est: 1.08B (+48.6%)
|
1.71B
est: 1.10B (+54.7%)
|
1.70B
est: 1.13B (+50.5%)
|
1.37B
est: 1.16B (+18.1%)
|
1.16B
est: 1.12B (+3.1%)
|
1.20B
est: 1.13B (+5.7%)
|
948.56M
est: 1.07B (-11.4%)
|
1.16B
est: 1.13B (+2.5%)
|
1.03B
est: 1.22B (-15.7%)
|
1.44B
est: 1.85B (-22.3%)
|
1.52B
est: 1.34B (+12.9%)
|
1.36B
1.36B – 1.36B
+1.0% YoY
|
1.41B
1.41B – 1.41B
+3.9% YoY
|
1.50B
1.50B – 1.50B
+6.6% YoY
|
| Net Income |
1.10B
est: 958.81M (+14.5%)
|
1.15B
est: 1.08B (+7.1%)
|
1.25B
est: 1.11B (+12.7%)
|
1.01B
est: 971.02M (+4.2%)
|
851.60M
est: 807.27M (+5.5%)
|
859.55M
est: 843.66M (+1.9%)
|
675.23M
est: 675.12M (+0.0%)
|
831.06M
est: 732.58M (+13.4%)
|
712.06M
est: 827.38M (-13.9%)
|
988.60M
est: 983.95M (+0.5%)
|
1.10B
est: 1.01B (+8.9%)
|
879.09M
879.09M – 879.09M
-12.8% YoY
|
879.09M
879.09M – 879.09M
+0.0% YoY
|
950.91M
950.91M – 950.91M
+8.2% YoY
|
| SGA |
2.09B
est: 1.96B (+6.9%)
|
2.15B
est: 2.00B (+7.4%)
|
2.19B
est: 2.05B (+6.9%)
|
2.14B
est: 2.10B (+2.0%)
|
2.13B
est: 2.04B (+4.4%)
|
2.02B
est: 2.05B (-1.6%)
|
1.94B
est: 1.94B (+0.2%)
|
2.09B
est: 2.04B (+2.4%)
|
2.11B
est: 2.21B (-4.8%)
|
2.24B
est: 2.38B (-5.7%)
|
2.58B
est: 2.47B (+4.5%)
|
2.50B
2.50B – 2.50B
+1.0% YoY
|
2.60B
2.60B – 2.60B
+3.9% YoY
|
2.77B
2.77B – 2.77B
+6.6% YoY
|
| EPS |
36.36
est: 33.38 (+8.9%)
|
38.45
est: 37.48 (+2.6%)
|
41.55
est: 38.50 (+7.9%)
|
33.79
est: 33.80 (0.0%)
|
29.05
est: 28.10 (+3.4%)
|
29.92
est: 29.37 (+1.9%)
|
23.50
est: 23.50 (+0.0%)
|
28.93
est: 25.50 (+13.5%)
|
24.79
est: 28.80 (-13.9%)
|
34.41
est: 34.25 (+0.5%)
|
38.21
est: 35.10 (+8.9%)
|
30.60
30.60 – 30.60
-12.8% YoY
|
30.60
30.60 – 30.60
+0.0% YoY
|
33.10
33.10 – 33.10
+8.2% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-14 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-05-13 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-12 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-11 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Dimensional - International Small Cap ETF DFIS | 0.00% | 28.1K | 0.39% |
| 2 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 44.2K | 0.22% |
| 3 | Dimensional World ex U.S. Core Equity 2 ETF DFAX | 0.00% | 16.4K | 0.28% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Keiichi Yamada | President, Chief Executive Officer, Director of the R&D Center and Chairman | — | male |
| Masayuki Yamada | Executive Vice President, Chief of Headquarters Business Administration Division & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 7775.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
